Rankiteo Logo
Rankiteo
Leader in Cyber Underwriting
Loading...
NEWRankiteo Cyber Underwriting Desktop - Score, price, and bind from your desktop
WindowsmacOSLinux
Download

Comparison Overview

INTERPHEX GlobalINTERPHEX Global
VS
MANKIND PHARMA LTDMANKIND PHARMA LTD
INTERPHEX Global

INTERPHEX Global

201 Merritt 7, Norwalk, 06851, US

Last Update: 14/12/2025

View Profile
756/1000Fair

Save the date to attend the leading global pharmaceutical and biotechnology event that fuses industry innovation with expert-led conference. April 21-23, 2025 | Javits Center, NYC RX Privacy Policy: https://privacy.rxglobal.com/

NAICS:3254
NAICS Definition:Pharmaceutical and Medicine Manufacturing
Employees:None
Subsidiaries:90
12-month incidents
0
Known data breaches
0
Attack type number
0
MANKIND PHARMA LTD

MANKIND PHARMA LTD

Phase 3, New Delhi, IN

Last Update: 06/09/2026

View Profile
Between 750 and 799
http://www.mankindpharma.com
781/1000Fair

Mankind Pharma, one of the top 5 leading pharmaceutical companies in India, started its journey in 1995. Today, we have an employee base of over 20,000 and are racing towards $1 Billion. At Mankind, we aspire to aid the community in leading a healthy life by formulating...

NAICS:3254
NAICS Definition:Pharmaceutical and Medicine Manufacturing
Employees:19,230
Subsidiaries:0
12-month incidents
0
Known data breaches
0
Attack type number
0

Compliance Ranges Comparison

Based On Specific Ai Models Category
INTERPHEX Global

INTERPHEX Global

-
ISO 27001Not verified
ISO 27001
-
SOC2 Type 1Not verified
SOC2 Type 1
-
SOC2 Type 2Not verified
SOC2 Type 2
-
GDPRNot verified
GDPR
-
PCI DSSNot verified
PCI DSS
-
HIPAANot verified
HIPAA
MANKIND PHARMA LTD

MANKIND PHARMA LTD

-
ISO 27001Not verified
ISO 27001
-
SOC2 Type 1Not verified
SOC2 Type 1
-
SOC2 Type 2Not verified
SOC2 Type 2
-
GDPRNot verified
GDPR
-
PCI DSSNot verified
PCI DSS
-
HIPAANot verified
HIPAA

Benchmark & Cyber Underwriting Signals

Incidents vs Pharmaceutical Manufacturing Industry Avg (This Year)

No incidents recorded for INTERPHEX Global in 2026.

Incidents

Incidents vs Pharmaceutical Manufacturing Industry Avg (This Year)

No incidents recorded for MANKIND PHARMA LTD in 2026.

Incidents

Incident History - INTERPHEX Global (X = Date, Y = Severity)

INTERPHEX Global cyber incidents detection timeline including parent company and subsidiaries.

R - Ransomware
C - Cyber Attack
D - Data Breach
V - Vulnerability

Incident History - MANKIND PHARMA LTD (X = Date, Y = Severity)

MANKIND PHARMA LTD cyber incidents detection timeline including parent company and subsidiaries.

No timeline data available
R - Ransomware
C - Cyber Attack
D - Data Breach
V - Vulnerability

Notable Incidents

Last Cyber / HR Incidents / Global...
INTERPHEX Global

INTERPHEX Global

Incidents
No explicit notable incidents reported.
MANKIND PHARMA LTD

MANKIND PHARMA LTD

Incidents
No explicit notable incidents reported.

FAQ

Between INTERPHEX Global company and MANKIND PHARMA LTD company, which one has the best AI Cybersecurity Score ?
Between INTERPHEX Global company and MANKIND PHARMA LTD company, which one has experienced more cyber incidents in the past ?
Between INTERPHEX Global company and MANKIND PHARMA LTD company, which one has experienced more cyber incidents this year ?
Between INTERPHEX Global company and MANKIND PHARMA LTD company, which one has experienced at least one ransomware attack ?
Between INTERPHEX Global company and MANKIND PHARMA LTD company, which one has experienced at least one data breach ?
Between INTERPHEX Global company and MANKIND PHARMA LTD company, which one has experienced at least one targeted cyberattack ?
Between INTERPHEX Global company and MANKIND PHARMA LTD company, which one has experienced at least one vulnerability ?
Between INTERPHEX Global company and MANKIND PHARMA LTD company, which one holds the most compliance certifications ?
Between INTERPHEX Global company and MANKIND PHARMA LTD company, which one holds the fewest compliance certifications ?
Between INTERPHEX Global company and MANKIND PHARMA LTD company, which one has the most subsidiaries ?
Between INTERPHEX Global company and MANKIND PHARMA LTD company, which one has the largest number of employees ?
Between INTERPHEX Global and MANKIND PHARMA LTD, which company holds both SOC 2 Type 1 certifications ?
Between INTERPHEX Global and MANKIND PHARMA LTD, which company holds both SOC 2 Type 2 certifications ?
Which company is ISO 27001 certified - INTERPHEX Global or MANKIND PHARMA LTD ?
Which company is PCI DSS compliant - INTERPHEX Global or MANKIND PHARMA LTD ?
Between INTERPHEX Global and MANKIND PHARMA LTD, which company complies with HIPAA regulations for healthcare data ?
Between INTERPHEX Global and MANKIND PHARMA LTD, which company complies with GDPR requirements ?

Latest Global CVEs

CVE-2026-103761
SUMMARY

Mooncake transfer engine through 0.3.13.post1 contains a memory exhaustion vulnerability in TransferMetadata::receivePeerNotify that allows unauthenticated attackers to grow process memory without limit. Attackers can repeatedly send notify frames up to 1 MB to the handshake RPC port, filling the uncapped notifys vector until the out-of-memory killer terminates the engine.

PUBLISHED
Date2026-10-01
UPDATED
Date2026-10-01
RISK INFORMATION (Score: 7.5)
CVSS3
Base Score: 7.5
Complexity: LOW
CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:N/I:N/A:H
CVSS4
Base Score: 8.7
Complexity: LOW
CVSS:4.0/AV:N/AC:L/AT:N/PR:N/UI:N/VC:N/VI:N/VA:H/SC:N/SI:N/SA:N/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X
IMPACT SCORE
3.6
EXPLOITABILITY
3.9
CVE-2026-103760
SUMMARY

Mooncake transfer engine through 0.3.13.post1 contains a denial of service vulnerability that allows unauthenticated remote attackers to block the handshake daemon by never reading replies. Attackers can send a Metadata request to the handshake RPC port and stall SocketHandShakePlugin's single listener thread in writeFully(), breaking all subsequent handshakes, metadata fetches, notify and probe requests.

PUBLISHED
Date2026-10-01
UPDATED
Date2026-10-01
RISK INFORMATION (Score: 5.9)
CVSS3
Base Score: 5.9
Complexity: HIGH
CVSS:3.1/AV:N/AC:H/PR:N/UI:N/S:U/C:N/I:N/A:H
CVSS4
Base Score: 8.2
Complexity: HIGH
CVSS:4.0/AV:N/AC:H/AT:P/PR:N/UI:N/VC:N/VI:N/VA:H/SC:N/SI:N/SA:N/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X
IMPACT SCORE
3.6
EXPLOITABILITY
2.2
CVE-2025-71427
SUMMARY

Office-PowerPoint-MCP-Server through 2.0.7 contains a path traversal vulnerability that allows MCP callers to write and read files outside the working directory by supplying absolute paths or ../ sequences. Attackers can steer an AI agent via prompt injection to abuse save_presentation, open_presentation, or manage_image output_path to overwrite any server-writable file or load external files.

PUBLISHED
Date2026-10-01
UPDATED
Date2026-10-01
RISK INFORMATION (Score: 6.8)
CVSS3
Base Score: 6.8
Complexity: HIGH
CVSS:3.1/AV:N/AC:H/PR:N/UI:R/S:U/C:H/I:H/A:N
CVSS4
Base Score: 7.6
Complexity: HIGH
CVSS:4.0/AV:N/AC:H/AT:P/PR:N/UI:P/VC:H/VI:H/VA:N/SC:N/SI:N/SA:N/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X
IMPACT SCORE
5.2
EXPLOITABILITY
1.6
CVE-2026-86344
SUMMARY

A flaw was found in 389-ds-base. An unauthenticated remote attacker can send a complete LDAP operation followed by the first bytes of an incomplete LDAPMessage on the same connection, causing the server to hand that connection to a second worker thread before the first worker's result is flushed. The second worker blocks until nsslapd-ioblocktimeout while holding the connection mutex, preventing delivery of the completed operation's result. Repeating this across a small number of connections proportional to the configured worker-thread pool size exhausts the entire pool under default configuration, denying service to all clients (anonymous and authenticated, plaintext and TLS) for as long as the attacker maintains the connections.

PUBLISHED
Date2026-10-01
UPDATED
Date2026-10-01
RISK INFORMATION (Score: 7.5)
CVSS3
Base Score: 7.5
Complexity: LOW
CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:N/I:N/A:H
IMPACT SCORE
3.6
EXPLOITABILITY
3.9
CVE-2026-71454
SUMMARY

Improper neutralization of input during web page generation ('cross-site scripting') vulnerability in CWE-79 - Cross-site Scripting CAPEC-63 allows Cross-Site Scripting (XSS). This issue affects CAPEC-63: before 3.0b63.

PUBLISHED
Date2026-10-01
UPDATED
Date2026-10-01
RISK INFORMATION (Score: )
CVSS4
Base Score: 5.8
Complexity: LOW
CVSS:4.0/AV:N/AC:L/AT:N/PR:L/UI:N/VC:L/VI:L/VA:L/SC:H/SI:H/SA:H/E:P/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X
IMPACT SCORE
NA
EXPLOITABILITY
NA